相关实验视频

Updated: Jan 9, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

作为潜在的PFOR向抗菌剂的尼塔佐克桑胺类同类的第一原则建模

Huda Alqahtani¹, Islam Gomaa², Ahmed Refaat^3,4

¹Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

International journal of molecular sciences

|December 11, 2025

概括

研究人员确定了一种"识别代码",用于抑制无氧性病原体中的pyruvate:ferredoxin氧降解酶 (PFOR). 这种基于关键分子相互作用的代码指导着新药的设计,以对抗这些疾病.

科学领域:

生物化学生物化学
药用化学医学化学
计算化学计算化学

背景情况:

酸铁氧降解酶 (PFOR) 是厌氧病原体中的关键酶,代表了一个潜在的治疗标.
尼塔佐克桑胺是一种已知的PFOR抑制剂,作为药物设计的基准.

研究的目的:

解读控制PFOR抑制的分子识别代码.
为开发具有提高疗效的新型PFOR抑制剂制定实用设计规则.

主要方法:

密度函数理论 (DFT) 计算用于电子结构分析.
化学信息量化结构与活动关系 (QSAR) 度量.
用残留物解决的分子对接模拟.

主要成果:

确定了一种含有与Thr-997和Cys-840的键的保守结合三元体,与Phe-869的π-π堆,以及与Thr-997的π-σ接触.
尼塔佐克桑化物去乙化为蒂佐克桑化物略有降低了结合亲和力.
战略化引入了有益的σ-孔相互作用,增强了新型类型中的结合亲和力和姿势几何.

结论:

一个最小的,可测试的PFOR抑制剂设计的配方包括保留一个的供体,保持与Thr-997/Cys-840和Phe-869的相互作用,并结合一个校准的素 σ-洞.
这些设计规则提供了可伪造的预测,以超越尼塔佐胺的疗效,并指导未来的合成和验证工作.

关键词:

在QSAR中使用QSAR.密度函数理论 (DFT) 是指密度函数理论.药物设计药物设计分子对接的分子对接.尼塔佐克桑化的使用方法铁酸盐:铁酸氧降解酶 (PFOR) 是一种这种类型的物质是tizoxanide.

更多相关视频

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

相关概念视频

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Antibiotic Selection

Antibiotic Selection